NASDAQ$MODVQ

Modivcare Inc · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Reported solid second quarter results with revenue growth driven by the non-emergency medical transportation business and increased 2022 guidance to account for strong performance.

Modivcare reported a revenue of $628.2 million, a 32.4% increase compared to Q2 2021. Net income was $3.3 million, or $0.24 per diluted common share. The company increased its 2022 guidance due to strong second quarter and year-to-date results.

  • Revenue of $628.2 million, a 32.4% increase as compared to $474.4 million in Q2 2021
  • Net income of $3.3 million or $0.24 per diluted common share
  • Adjusted EBITDA of $60.2 million and Adjusted EPS of $1.99
  • 2022 guidance increased to account for strong second quarter and year-to-date results

Headline financials

Total Revenue

$628M

Previous: $474M+32.4%
EPS (adj)

$1.99

Previous: $2.13-6.6%
Capital Expenditures

-$15.9M

Previous: -$8.13M-95.5%
Free Cash Flow

$35.3M

Previous: $161M-78.1%
Net Income

$3.33M

Previous: $13.7M-75.7%
Operating Income

$23.1M

Previous: $27.6M-16.0%
Gross Profit

$124M

Previous: $94.9M+30.7%
Cash & Equivalents

$88M

Previous: $291M-69.7%
Total Assets

$2.06B

Previous: $1.58B+30.7%
Stock-Based Comp

$2.45M

Previous: $1.47M+66.2%

Revenue & EPS history

Modivcare · Revenue · Quarterly

$628M

Q2 2022+32.4%vs Q2 2021
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Forward guidance

The company updated its 2022 guidance and expects revenue between $2,375 million and $2,400 million, and adjusted EBITDA between $210 million and $220 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 6 quarterly earnings reports

Historical avg

+0.1%

Avg return

Earnings day

-10.6%

Avg return

5 days after

+29.9%

Avg return

30 days after

53%

33 / 62 earnings

Positive

+21.0%

Q1 2024

Best reaction

-41.0%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025
Q1 2025-11.4%-26.5%+198.5%
Q4 2024-22.5%-35.9%-68.1%
Q3 2024+10.6%-0.7%+11.3%
Q2 2024+15.8%+18.8%+59.8%
Q1 2024+21.0%+18.5%+23.0%
Q4 2023-41.0%-37.7%-44.9%
Q3 2023+14.5%
Q2 2023-4.4%
Q1 2023-21.6%
Q4 2022-1.6%
Q3 2022-5.9%
Q2 2022+2.0%
Q1 2022-7.2%
Q4 2021+16.5%
Q3 2021-8.8%
Q2 2021-1.2%
Q1 2021+2.0%
Q4 2020-15.4%
Q3 2020+4.1%
Q2 2020+8.8%
Q1 2020+7.9%
Q4 2019-9.2%
Q3 2019+5.2%
Q2 2019+2.6%
Q1 2019+2.3%
Q4 2018+0.1%
Q3 2018+11.4%
Q2 2018-9.3%
Q1 2018-6.3%
Q4 2017+7.6%
Q3 2017+5.2%
Q2 2017+0.0%
Q1 2017+10.3%
Q4 2016+8.8%
Q3 2016-7.0%
Q2 2016-1.7%
Q1 2016-0.8%
Q4 2015+16.3%
Q3 2015-14.6%
Q2 2015-0.8%
Q1 2015+12.2%
Q4 2014+9.9%
Q3 2014-11.3%
Q2 2014+17.8%
Q1 2014-2.7%
Q4 2013-10.4%
Q3 2013-11.7%
Q2 2013+0.7%
Q1 2013+6.7%
Q4 2012+5.1%
Q3 2012+16.4%
Q2 2012-14.7%
Q1 2011-0.9%
Q1 2012+0.6%
Q4 2009-2.2%
Q4 2011-2.2%
Q3 2010-2.3%
Q3 2011-2.3%
Q2 2011+4.3%
Q2 2010+4.3%
Q4 2010+4.3%
Q1 2010+1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro